We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MOXONIDINE LAPL, MOXONIDINE GENERICHEALTH, MOXONIDINE GH (Lupin Australia Pty Limited)
Product name
MOXONIDINE LAPL, MOXONIDINE GENERICHEALTH, MOXONIDINE GH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
150 working days (255)
Active ingredients
Moxonidine
Registration type
New generic medicine
Indication
MOXONIDINE LAPL, MOXONIDINE GENERICHEALTH, MOXONIDINE GH (tablets) is indicated for the treatment of hypertension.